Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01368614 · ClinicalTrials.gov registry record · NA
AVAPS-AE Efficacy Study
A NA study, sponsored by Philips Respironics.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT01368614 is a NA study that has completed, run by Philips Respironics. The registered enrollment target is 90 participants.
The verdict
NCT01368614, a NA study, has completed, sponsored by Philips Respironics.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the feasibility of using of the Average Volume Assured Pressure Support (AVAPS-AE) mode versus Continuous Positive Airway Pressure (CPAP) and bilevel pressure support ventilation (PSV) modes of ventilation in patients diagnosed with Obesity Hypoventilation syndrome (OHS). The investigators believe the use of the AVAPS-AE mode of ventilation after 6 weeks will yield daytime gas exchange values which are equivalent or no worse when compared to using CPAP and bilevel PSV modes of ventilation in the OHS population.
Interventions
- DEVICE AVAPS-AE Mode of Therapy
- DEVICE Respironics OnmiLab BiPAP S mode
- DEVICE Respironics OmniLab Advanced CPAP mode
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2011-09-12 |
| Est. Completion | 2013-05-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01368614
The ClinicalTrials.gov registry entry for NCT01368614 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Philips Respironics, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which AVAPS-AE Mode of Therapy is the first listed.
NCT01368614 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01368614 about?
NCT01368614 is a clinical study titled "AVAPS-AE Efficacy Study". The purpose of this study is to evaluate the feasibility of using of the Average Volume Assured Pressure Support (AVAPS-AE) mode versus Continuous Positive Airway Pressure (CPAP) and bilevel pressure support ventilation (PSV) modes of ventilation in patients diagnosed with Obesity Hypoventilation sy...
What is the current status of trial NCT01368614?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2011-09-12. Estimated completion is 2013-05-30.
What interventions are being tested in trial NCT01368614?
The interventions under investigation include: AVAPS-AE Mode of Therapy (DEVICE), Respironics OnmiLab BiPAP S mode (DEVICE), Respironics OmniLab Advanced CPAP mode (DEVICE).
Who is sponsoring clinical trial NCT01368614?
This trial is sponsored by Philips Respironics, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.